Vnitr Lek 2012, 58(5):396-399

Calcitriol endocrine microsystems - developmental aspects and prerequisites for their lifelong functionality

B. Kalvachová
Endokrinologický ústav Praha, ředitelka doc. RNDr. Běla Bendlová, CSc.

New findings regarding the local synthesis of calcitriol, its binding on nuclear receptors and its regional tissue effects have led to discovery of its endocrine microsystems. Their application in growing organisms and their lifelong functionality provide possible preventive and treatment modalities in multiple ailments, mostly by natural and minimally expensive means.

Keywords: calcitriol endocrine microsystems; children; saturation factors; cholecalciferol daily need; supplementation

Received: September 30, 2011; Published: May 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kalvachová B. Calcitriol endocrine microsystems - developmental aspects and prerequisites for their lifelong functionality. Vnitr Lek. 2012;58(5):396-399.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Borissova AM, Tankova T, Kirilov G et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003; 57: 258-261. Go to original source... Go to PubMed...
    2. Calvo MS, Whiting SJ. Overview of the Proceedings from Experimental Biology 2004 Symposium: Vitamin D Insufficiency: A Significant Risk Factor in Chronic Diseases and Potential Disease-Specific Biomarkers of Vitamin D Sufficiency. J Nutr 2005; 135: 301-303. Go to original source... Go to PubMed...
    3. Dawson-Hughes B, Heaney RP, Holick MF et al. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-716. Go to original source... Go to PubMed...
    4. Hayes CE, Nashold FE, Spach KM et al. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-Grand) 2003; 49: 277-300.
    5. Heaney RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005; 97: 13-19. Go to original source... Go to PubMed...
    6. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281. Go to original source... Go to PubMed...
    7. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135: 317-322. Go to original source... Go to PubMed...
    8. Kalvachová B. Vitamin D - nové poznatky a endokrinní mikrosystémy kalcitriolu. Osteologický Bulletin 2007; 2: 62-67.
    9. Keen RW, Egger P, Fall C et al. Polymorphisms of the Vitamin D Receptor, Infant Growth and Adult Bone Mass. Calcif Tissue Int 1997; 60: 233-235. Go to original source... Go to PubMed...
    10. McGrath J. Does "imprinting" with low prenatal vitamin D contribute to the risk of various adult disorders? Med Hypotheses 2001; 56: 367-371. Go to original source... Go to PubMed...
    11. Paszková H. Profylaktické a terapeutické využití vitaminu D od rachitidy přes osteoporózu až k degenerativním kloubním onemocněním. Rehabil fyz lék 2000; 7: 16-20.
    12. Posonby AL, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002; 27: 71-78. Go to original source... Go to PubMed...
    13. Vieth R. Vitamin D Nutrition and Its Potential Health Benefits for Bone, Cancer and Other Conditions. J Nutr Environ Med 2001; 11: 275-291. Go to original source...
    14. Waterland RA, Garza C. Potential mechanisms of metabolic imprinting that lead to chronic disease. Am J Clin Nutr 1999; 69: 179-197. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.